The short version
- The Medical Psilocybin Act was signed in April 2025, the first psilocybin access law passed by a state legislature.
- Qualifying conditions: treatment-resistant depression, PTSD, substance use disorders, and end-of-life care.
- Producer permit applications opened August 17, 2026. Clinician permits haven't opened yet.
- The state's goal is late 2026. The legal deadline is December 31, 2027.
The law
Governor Michelle Lujan Grisham signed SB 219, the Medical Psilocybin Act, on April 7, 2025. Oregon and Colorado created their programs through ballot measures. New Mexico's came from its legislature, a first. The law also carves psilocybin used under the program out of the state's Schedule I list.1
Unlike Oregon and Colorado, where any adult 21 or older can participate, New Mexico's program is medical. Patients need a qualifying condition and treatment by a licensed health care provider in an approved setting.1
Who qualifies
- Treatment-resistant depression
- Post-traumatic stress disorder
- Substance use disorders
- End-of-life care
A state advisory board can recommend adding more conditions later.2
Progress so far
| Date | Milestone |
|---|---|
| April 2025 | Medical Psilocybin Act signed1 |
| December 2025 | Advisory board's first meeting; state announces goal of treating patients by end of 2026, a year early4 |
| March 2026 | $630,000 treatment equity fund for low-income patients signed into law, plus $300,000 for end-of-life research at the University of New Mexico3 |
| August 17, 2026 | Producer permit applications open2 |
| Pending | Clinician permits and final rules for treatment |
| December 31, 2027 | Statutory deadline for full implementation2 |
The equity fund
This is the part other states should copy. One of the biggest criticisms of Oregon's program is cost: sessions often run hundreds to thousands of dollars, insurance doesn't cover them, and clients skew wealthy. New Mexico set aside $630,000 so residents can receive treatment regardless of income, the first fund of its kind in the country.3 Details on eligibility were still being worked out.
The hurdles
The end-of-2026 goal looks ambitious. Clinicians can't apply for permits yet, the rules for treatment aren't final, and all psilocybin used in the program has to be produced and tested inside New Mexico, which means producers need time to get licensed and grow.2 Realistically, the first patients may be treated sometime in 2027.
A native connection
New Mexico has its own psilocybin mushroom: Psilocybe mescaleroensis, the most common psilocybin species growing wild in the state.5 The program will be using cultivated mushrooms, not wild ones, but it's a nice bit of local history.
What to do if you're interested
If you live in New Mexico and have a qualifying condition, talk to your doctor and watch the New Mexico Department of Health for clinician permit announcements. We'll add New Mexico providers to our psilocybin therapist finder as soon as they're licensed.
Sources
- Foley & Lardner. New Mexico becomes third state in the U.S. to legalize access to psilocybin. 2025. foley.com
- HealingMaps. New Mexico just opened its first psilocybin permits. The one clinicians need is still coming. 2026. healingmaps.com
- KUNM. New Mexico creates first-ever medical psilocybin fund for low-income patients. March 17, 2026. kunm.org
- HealingMaps. New Mexico accelerates psilocybin therapy program, beating original deadline by a year. healingmaps.com
- Mugglehead. New Mexico regulators announce plans to launch medical psilocybin program 1 year early. 2026. mugglehead.com
This article is for education only and is not medical or legal advice. Psilocybin is a Schedule I substance under U.S. federal law. Talk with a licensed clinician before making decisions about your health. In a crisis, call or text 988.